Literature DB >> 19870421

THE PROTECTIVE ACTION OF TYPE I ANTIPNEUMOCOCCUS SERUM IN MICE : I. THE QUANTITATIVE ASPECTS OF THE MOUSE PROTECTION TEST.

K Goodner1, F L Horsfall.   

Abstract

The mouse protection test for the evaluation of type specific antipneumococcus serum has been studied with reference to the quantitative relationships between the amount of antibody and the number of injected bacteria. By varying both these factors through wide limits certain definite characteristics of the protection test have been defined. These are the Schwellenwert, the prozone, and the limiting titer zone. The modifications produced in the manifestations of these characteristics by changes in the technic of performing the test and also by certain non-specific reagents are described. The dependence of the outcome of the test upon variable factors intrinsic to the host is discussed.

Entities:  

Year:  1935        PMID: 19870421      PMCID: PMC2133282          DOI: 10.1084/jem.62.3.359

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  2 in total

1.  STUDIES ON HOST FACTORS IN PNEUMOCOCCUS INFECTIONS : II. THE PROTECTIVE ACTION OF TYPE I ANTIPNEUMOCOCCUS SERUM IN RABBITS.

Authors:  K Goodner
Journal:  J Exp Med       Date:  1934-06-30       Impact factor: 14.307

2.  STUDIES ON HOST FACTORS IN PNEUMOCOCCUS INFECTIONS : I. CERTAIN FACTORS INVOLVED IN THE CURATIVE ACTION OF SPECIFIC ANTIPNEUMOCOCCUS SERUM IN TYPE I PNEUMOCOCCUS DERMAL INFECTION IN RABBITS.

Authors:  K Goodner
Journal:  J Exp Med       Date:  1934-06-30       Impact factor: 14.307

  2 in total
  21 in total

1.  [Not Available].

Authors:  K E VOGT
Journal:  Z Hyg Infektionskr       Date:  1948

Review 2.  Antibody immunity and invasive fungal infections.

Authors:  A Casadevall
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

3.  Protective and immunochemical activities of monoclonal antibodies reactive with the Bacillus anthracis polypeptide capsule.

Authors:  Thomas R Kozel; Peter Thorkildson; Suzanne Brandt; William H Welch; Julie A Lovchik; David P AuCoin; Julpohng Vilai; C Rick Lyons
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

4.  The relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response.

Authors:  Oscar Zaragoza; Mauricio Alvarez; Andrew Telzak; Johanna Rivera; Arturo Casadevall
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

5.  A comprehensive mathematical model for three-body binding equilibria.

Authors:  Eugene F Douglass; Chad J Miller; Gerson Sparer; Harold Shapiro; David A Spiegel
Journal:  J Am Chem Soc       Date:  2013-04-16       Impact factor: 15.419

6.  Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae.

Authors:  D E Briles; M Nahm; K Schroer; J Davie; P Baker; J Kearney; R Barletta
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

7.  Bacteriophage-resistant Staphylococcus aureus mutant confers broad immunity against staphylococcal infection in mice.

Authors:  Rosanna Capparelli; Nunzia Nocerino; Rosa Lanzetta; Alba Silipo; Angela Amoresano; Chiara Giangrande; Karsten Becker; Giuseppe Blaiotta; Antonio Evidente; Alessio Cimmino; Marco Iannaccone; Marianna Parlato; Chiara Medaglia; Sante Roperto; Franco Roperto; Luigi Ramunno; Domenico Iannelli
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

8.  Modulation of polymorphonuclear cell interleukin-8 secretion by human monoclonal antibodies to type 8 pneumococcal capsular polysaccharide.

Authors:  Tamika Burns; Zhaojing Zhong; Michael Steinitz; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

9.  Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types.

Authors:  S C Szu; S Clarke; J B Robbins
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

10.  Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice.

Authors:  Haijun Tian; Sarah Weber; Peter Thorkildson; Thomas R Kozel; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.